More Than Pathogen Reduction: Seraph 100 In COVID-19 Patients

More Than Pathogen Reduction: Seraph 100 In COVID-19 Patients

Panelists:

Professor Jan Kielstein 

(Klinikum Braunschweig, Germany) 

Doctor Julius Schmidt 

(Hannover Medical School, Germany) 

Doctor Steven Stogner 

(Forrest General Hospital in Hattiesburg, Mississippi, USA) 

Doctor Brian Rifkin 

(Forrest General Hospital in Hattiesburg, Mississippi, USA)

Find ExThera Medical On Social Media 


Exhibit

Symposia

Workshops

Organiser

Sponsor



EXTHERA

ExThera Medical was formed in 2007 through a joint venture between the Emergence Venture Partners Life Science Incubator and ExThera AB, at the Karolinska Institute of Stockholm. We are focused on therapeutic applications to treat drug-resistant and drug-susceptible bloodstream infections in high-risk patient populations, with field deployable versions for biodefense and military.


The company’s first product, the Seraph® 100 Microbind® Affinity Blood Filter, is CE Marked for the reduction of pathogens during bloodstream infections in adjunction to antibiotics and commercially available in Europe.

Registration available online here




Related articles

More events

ESRA 2024

Wed, 4 Sep 2024 - Sat, 7 Sep 2024


5. května 1640
Prague 4, 140 00
Czech Republic
ERS Congress 2024

Sat, 7 Sep 2024 - Wed, 11 Sep 2024


Messeplatz 1
Wien, 1020
Austria